Exploring How Healthcare Professionals Diagnose and Manage Vitiligo: Global VALIANT Study Findings and Recommendations

• by Khaled Ezzedine, John E. Harris, Iltefat H. Hamzavi, Nanja van Geel, Kristen Bibeau, Jessy Gao, Haobo Ren, Pearl Grimes

• October 28, 2026

CDC flags neuro symptoms after unapproved botulinum toxin

None of the 3 symptomatic patients knew the injected product lacked FDA approval.

• by Teraya Smith

• October 9, 2026

• 3 min

Diagnostic Value of Skin Biopsy in Fatal Histoplasmosis-Associated Hemophagocytic Lymphohistiocytosis: A Case Report

• by Jaclyn Roland-McGowan, Riyad N. H. Seervai, Claudia Lee, Stephanie Mengden Koon, Jesse J. Keller

• October 13, 2026

Alopecia therapy gains FDA breakthrough status

The designation covers an investigational botanical treatment for moderate-to-severe alopecia areata in patients aged 2 years and older.

• by Teraya Smith

• October 13, 2026

• 2 min